Literature DB >> 21821522

How and when do myocytes die during ischemia and reperfusion: the late phase.

Christopher P Baines1.   

Abstract

While the majority of the cardiac myocyte death that makes up the final infarct occurs during ischemia and the first few minutes of reperfusion, cell death does not stop there. In fact necrosis and apoptosis, and potentially autophagy, can continue in the previously ischemic area for up to 3 days post-reperfusion. Several mechanisms can potentially contribute to this death continuum: (1) myocytes that have already passed the point of no return despite reperfusion; (2) continued dysfunction of the coronary microvasculature; and (3) infiltration of inflammatory cells. The latter in particular leads to elevated myocardial concentrations of reactive oxygen species (ROS), inflammatory cytokines, activation of toll-like receptors, secretion of toxic enzymes, and activation of the complement cascade--all of which can lead to myocyte death. However, there is a considerable lack of studies that comprehensively examine the time course, nature, and mechanisms of post-reperfusion myocyte death. Moreover, cell death types (apoptosis, necrosis, and autophagy) are inextricably linked to one another. Therefore, we do not know whether specific blockade of necrosis during the acute phase of myocyte death will instead enhance apoptosis during the late phase, that is, will we be simply delaying the inevitable? Consequently, the purpose of this article is to briefly review what we do, and more importantly what we do not, know about cardiac cell death in the reperfused heart and what is needed to advance our understanding of this phenomenon.

Entities:  

Mesh:

Year:  2011        PMID: 21821522     DOI: 10.1177/1074248411407769

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol Ther        ISSN: 1074-2484            Impact factor:   2.457


  31 in total

Review 1.  Mitochondrial membrane potential.

Authors:  Ljubava D Zorova; Vasily A Popkov; Egor Y Plotnikov; Denis N Silachev; Irina B Pevzner; Stanislovas S Jankauskas; Valentina A Babenko; Savva D Zorov; Anastasia V Balakireva; Magdalena Juhaszova; Steven J Sollott; Dmitry B Zorov
Journal:  Anal Biochem       Date:  2017-07-12       Impact factor: 3.365

Review 2.  Autophagy, a process within reperfusion injury: an update.

Authors:  Bisharad Anil Thapalia; Zhen Zhou; Xianhe Lin
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

Review 3.  Ischemia/Reperfusion.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Compr Physiol       Date:  2016-12-06       Impact factor: 9.090

Review 4.  Cell biology of ischemia/reperfusion injury.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

Review 5.  Direct effects of adipokines on the heart: focus on adiponectin.

Authors:  Min Park; Gary Sweeney
Journal:  Heart Fail Rev       Date:  2013-09       Impact factor: 4.214

6.  Reduction of early reperfusion injury with the mitochondria-targeting peptide bendavia.

Authors:  David A Brown; Sharon L Hale; Christopher P Baines; Carlos L del Rio; Robert L Hamlin; Yukie Yueyama; Anusak Kijtawornrat; Steve T Yeh; Chad R Frasier; Luke M Stewart; Fatiha Moukdar; Saame Raza Shaikh; Kelsey H Fisher-Wellman; P Darrell Neufer; Robert A Kloner
Journal:  J Cardiovasc Pharmacol Ther       Date:  2013-11-28       Impact factor: 2.457

Review 7.  The ubiquitin proteasome system and myocardial ischemia.

Authors:  Justine Calise; Saul R Powell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-07       Impact factor: 4.733

8.  Parthenolide-Induced Cytotoxicity in H9c2 Cardiomyoblasts Involves Oxidative Stress.

Authors:  Tien-Yao Tsai; Paul Chan; Chi-Li Gong; Kar-Lok Wong; Tzu-Hui Su; Pei-Chen Shen; Yuk-Man Leung; Zhong-Min Liu
Journal:  Acta Cardiol Sin       Date:  2015-01       Impact factor: 2.672

9.  Positive feedback in cardioprotection: can more mechanism lead to translation?

Authors:  Douglas J Chapski; Emma Monte; Thomas M Vondriska
Journal:  Circ Res       Date:  2014-04-11       Impact factor: 17.367

10.  Inhibition of the cardiomyocyte-specific kinase TNNI3K limits oxidative stress, injury, and adverse remodeling in the ischemic heart.

Authors:  Ronald J Vagnozzi; Gregory J Gatto; Lara S Kallander; Nicholas E Hoffman; Karthik Mallilankaraman; Victoria L T Ballard; Brian G Lawhorn; Patrick Stoy; Joanne Philp; Alan P Graves; Yoshiro Naito; John J Lepore; Erhe Gao; Muniswamy Madesh; Thomas Force
Journal:  Sci Transl Med       Date:  2013-10-16       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.